Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Psilocybin Microdosing on Cognition, Mood and Quality of Life: A Pilot Study

NCT07449351 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT07449351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07449351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Psilocybin Microdosing on Cognition, Mood and Quality of Life: A Pilot Study
Lead sponsor
Yale University
Phase
Phase 1
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
April 1, 2028
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psychedelic microdosing effects on mood, cognition, subjective well-being and mri